Skip to Main Content

1,438

Views

1

CrossRef citations to date

0

Altmetric

Research Paper

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults

Goran StevanovicClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaCorrespondence[email protected]
View further author information

,

Lidija LavadinovicClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information

,

Svetlana Filipovic VignjevicDiagnostics and Research and Development, Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information

,

Renée HoltCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information

,

Katarina IlicDiagnostics and Research and Development, Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information

,

Francesco Berlanda ScorzaCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information

,

Erin SparrowUniversal Health Coverage and Health Systems, The World Health Organization, Geneva, SwitzerlandView further author information

,

Vera StoiljkovicManaging Director of the Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information

,

Guido TorelliUniversal Health Coverage and Health Systems, The World Health Organization, Geneva, SwitzerlandView further author information

,

Tamra MadenwaldCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information

,

Muriel SocquetCenter for Vaccine Innovation and Access, PATH, Geneva, SwitzerlandView further author information

,

Aleksandra BaracClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information

,

Yordanka Ilieva-BorisovaComac Medical, Sofia, BulgariaView further author information

,

Mijomir PelemisClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information

&

Jorge FloresCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information